
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Alexandria Real Estate Equities Inc (ARE)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/15/2025: ARE (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $96.42
1 Year Target Price $96.42
3 | Strong Buy |
1 | Buy |
9 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -24.95% | Avg. Invested days 20 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 14.50B USD | Price to earnings Ratio - | 1Y Target Price 96.42 |
Price to earnings Ratio - | 1Y Target Price 96.42 | ||
Volume (30-day avg) 13 | Beta 1.31 | 52 Weeks Range 66.16 - 118.71 | Updated Date 09/15/2025 |
52 Weeks Range 66.16 - 118.71 | Updated Date 09/15/2025 | ||
Dividends yield (FY) 6.21% | Basic EPS (TTM) -0.13 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -0.33% | Operating Margin (TTM) 20.36% |
Management Effectiveness
Return on Assets (TTM) 1.2% | Return on Equity (TTM) 0.78% |
Valuation
Trailing PE - | Forward PE 16.69 | Enterprise Value 27634604971 | Price to Sales(TTM) 4.68 |
Enterprise Value 27634604971 | Price to Sales(TTM) 4.68 | ||
Enterprise Value to Revenue 9.15 | Enterprise Value to EBITDA 16.34 | Shares Outstanding 170720992 | Shares Floating 154047617 |
Shares Outstanding 170720992 | Shares Floating 154047617 | ||
Percent Insiders 0.99 | Percent Institutions 95.73 |
Upturn AI SWOT
Alexandria Real Estate Equities Inc

Company Overview
History and Background
Alexandria Real Estate Equities, Inc. (ARE) was founded in 1994. It focuses on developing and operating properties for the life science, technology, and agtech industries. It was one of the first REITs to specialize in this niche.
Core Business Areas
- Leasing: Leasing lab space and office buildings to life science, technology, and agtech companies.
- Development and Redevelopment: Developing new properties and redeveloping existing ones to meet the specific needs of tenants.
- Property Management: Managing properties, including maintenance, security, and tenant services.
Leadership and Structure
The company is led by Joel S. Marcus (Executive Chairman and Founder). Marc Bazin is the Chief Executive Officer. The organizational structure includes departments for development, leasing, finance, and property management.
Top Products and Market Share
Key Offerings
- Lab Space: Specialized laboratory facilities for pharmaceutical, biotechnology, and other life science companies. ARE is a leading provider of such space, but definitive market share data is difficult to ascertain. Competitors include Boston Properties (BXP) and Healthpeak Properties (PEAK).
- Office Buildings: Office space tailored to the needs of technology and agtech companies. Market share information is difficult to ascertain. Competitors include SL Green Realty Corp (SLG) and Vornado Realty Trust (VNO).
Market Dynamics
Industry Overview
The life science, technology, and agtech industries are experiencing growth, driving demand for specialized real estate. This growth is due to increased funding, research and development activities, and technological advancements.
Positioning
Alexandria Real Estate Equities, Inc. is a leading REIT in the life science, technology, and agtech real estate niche. Its competitive advantage lies in its expertise in developing and managing properties for these industries.
Total Addressable Market (TAM)
The TAM for life science real estate is estimated to be in the tens of billions of dollars. Alexandria is well positioned to capture a significant portion of this TAM due to its established presence and specialized expertise.
Upturn SWOT Analysis
Strengths
- Specialized Expertise
- High-Quality Portfolio
- Strong Tenant Relationships
- Geographically Concentrated Portfolio
Weaknesses
- Concentration in Specific Industries
- High Development Costs
- Exposure to Economic Downturns
- High debt load
Opportunities
- Growing Demand for Lab Space
- Expansion into New Markets
- Increasing Research and Development Funding
- Develop new properties with advanced technologies
Threats
- Economic Recession
- Increased Competition
- Changes in Government Regulations
- Rising Interest Rates
Competitors and Market Share
Key Competitors
- BXP
- PEAK
- SLG
- VNO
Competitive Landscape
Alexandria Real Estate Equities, Inc. has a competitive advantage due to its specialized expertise and high-quality portfolio. However, it faces competition from other REITs and developers. Some competitors have broader investment mandates that allow them flexibility.
Major Acquisitions
BioMed Realty Trust
- Year: 2016
- Acquisition Price (USD millions): 8000
- Strategic Rationale: Expanded ARE's portfolio and strengthened its position in key life science markets.
Growth Trajectory and Initiatives
Historical Growth: Alexandria Real Estate Equities, Inc. has experienced significant growth in recent years due to the increasing demand for lab space and office buildings in the life science, technology, and agtech industries.
Future Projections: Future growth projections require access to analyst estimates, available from financial data providers.
Recent Initiatives: Recent initiatives require access to company announcements and news releases, available from ARE's investor relations website.
Summary
Alexandria Real Estate Equities, Inc. is a strong company due to its specialized focus and high-quality properties. Its focus on the life science, technology, and agtech industries allows it to command premium rents. It should be cautious about economic downturns and rising interest rates due to the nature of Real Estate.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company reports
- Analyst reports
- Industry publications
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market share data is approximate and may vary. Financial data needs to be verified with updated quarterly reports.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Alexandria Real Estate Equities Inc
Exchange NYSE | Headquaters Pasadena, CA, United States | ||
IPO Launch date 1997-05-27 | CEO & Chief Investment Officer Mr. Peter M. Moglia | ||
Sector Real Estate | Industry REIT - Office | Full time employees 552 | Website https://www.are.com |
Full time employees 552 | Website https://www.are.com |
Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of June 30, 2025, Alexandria has a total market capitalization of $25.7 billion and an asset base in North America that includes 39.7 million RSF of operating properties and 4.4 million RSF of Class A/A+ properties undergoing construction and one 100% pre-leased committed near-term project expected to commence construction in the next year. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.